Publications 1999 [References 32–51]

32. Bartlett MJ, Burgess MA, McIntyre PB, Heath TC. Parent and general practitioner preferences for infant immunisation: reactogenicity or multiple injections? Aust Fam Physician 1999;28 Suppl:S22-7. [abstract]

33. Burgess MA, Cossart YE, Wilkins TD, Botham S, Fearns G, Chitour K. Varicella vaccination of health-care workers. Vaccine 1999;17:765-9. [abstract]

34. Achat H, McIntyre P, Burgess M. Health care incentives in immunisation. Aust N Z J Public Health 1999;23:285-8. [abstract]

35. O'Brien E, D'Souza R, Gilroy N, Burgess M, Lister S, McIntyre P, Torvaldsen S, Moser K, Milton A. Australia's notifiable disease status, 1997. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 1999;23:1-27. [full text]

36. Heath T, Burgess M, McIntyre P, Catton M. The National Measles Surveillance Strategy. The National Centre for Disease Control Measles Elimination Advisory Committee. Commun Dis Intell 1999;23:41-9. [full text]

37. Burgess MA, McIntyre PB. Vaccine-associated paralytic poliomyelitis. Commun Dis Intell 1999;23:80-1. [full text]

38. Amin J, Heath T, Morrell S. Hepatitis A in Australia in the 1990s: future directions in surveillance and control. Commun Dis Intell 1999;23:113-20. [full text]

39. Lister S, McIntyre PB, Burgess MA, O'Brien ED. Immunisation coverage in Australian children: a systematic review 1990-1998. Commun Dis Intell 1999;23:145-70. [full text]

40. Sullivan E, Burgess MA, Forrest JM. The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997. Commun Dis Intell 1999;23:209-14. [full text]

41. Amin J, Wong M. Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update. Commun Dis Intell 1999;23:222. [full text]

42. Thomson J, Lin M, Halliday L, Preston G, McIntyre P, Gidding H, Amin J, Roberts L, Higgins K, Brooke F, Milton A, O'Brien E, Witteveen D, Crerar S. Australia's notifiable disease status, 1998. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 1999;23:277-305. [abstract]

43. Liddle JL, McIntyre PB, Davis CW. Incidence of invasive pneumococcal disease in Sydney children, 1991-96. J Paediatr Child Health 1999;35:67-70. [abstract]

44. Kappagoda C, Shaw PJ, Burgess MA, Botham SJ, Cramer LD. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia. Paediatr Child Health 1999;35:341-5. [abstract]

45. Goodwin H, Nash M, Gold M, Heath TC, Burgess MA. Vaccination of children following a previous hypotonic hyporesponsive episode. J Paediatr Child Health 1999;35:549-52. [abstract]

46. Burgess MA, McIntyre PB. Vaccines and the cold chain: is it too hot . . . or too cold? [editorial] Med J Aust 1999;171:82. [no abstract available]

47. Arestis N, Tham YJ, McIntyre PB, Isaacs D, Palasanthiran P, Ferguson JK, Wilkinson I, Dawson D, Christensen AJ. A population-based study of childre with cerebral tuberculosis in New South Wales. Med J Aust 1999;171:197-200. [abstract]

48. Hull BP, McIntyre PB, Heath TC, Sayer GP. Measuring immunisation coverage in Australia. A review of the Australian Childhood Immunisation Register. Aust Fam Physician 1999;28:55-60. [abstract]

49. Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia. Vaccine 1999;18:407-15. [abstract]

50. Daley AJ, McIntyre P, Kakakios A, Isaacs D. Ulcerative lesion of the nasal bridge in a five-month-old infant. Pediatr Infect Dis J 1999;18:936-7. [no abstract available]

51. Guevarra MVC, Gupta L, Heath TC, Burgess MA. A statewide survey of general practitioners in NSW, Australia, about immunisation and strategies to increase childhood immunisation rates. Asia Pac J Public Health 1999;11(1):20-5. [abstract]